About Hilda

Hilda’s practice focuses on US and Hong Kong capital markets and other corporate matters. She has advised industry‑leading companies and investment banks on a wide range of capital markets transactions, including U.S. and Hong Kong IPOs, de‑SPAC listings, follow‑on offerings, ATM offerings and PIPEs, across the life sciences, AI, blockchain, consumer and other sectors. She has been actively involved in several high‑profile listings, including those of Insilico Medicine, WeRide, Duality Biologics, Bitdeer and Gracell Biotechnologies. She also regularly advises public companies on compliance and U.S. securities law matters.

View full bio

Experience

View more

Admissions and credentials

  • New York
  • Hong Kong (Registered Foreign Lawyer)

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.